Researchers find hundreds of clinics marketing selling stem cell interventions in US

02 Jul 2016

1

Contrary to popular perception, about experimental medical procedures being conducted in countries where lawlessness or lax supervision prevailed, two researchers have found 351 businesses selling stem cell interventions from 570 American-based clinics.

The researchers conducted a keyword-based internet search and analysis.

The businesses marketed which directly to consumers and in some cases to desperate patients in failing health often advertised types of stem cell treatments that did to fit the Food and Drug Administration's (FDA) regulations.

"When you go on the Internet, what comes up, the first thing you see are these businesses," said Leigh Turner, co-author of the study. He added that many sites appear to intentionally blur the distinctions between approved, evidence-based scientific practices and quack procedures, edition.cnn.com reported. "The websites are well-done, with links to scientific studies and patient testimonials."

"It's a jungle out there," said Paul Knoepfler, co-author of the study and a stem cell scientist, adding that some treatment centers will call what they're doing "a clinical trial" when it's nothing of the sort. Instead, it's simply a for-profit center administering experimental procedures to earn income. "In college, I had friends participating in experimental trials, and they got paid," he said.

Such clinics could offer dangerous, often exorbitantly priced ''treatments.'' Their targets were usually the vulnerable and desperate, including terminal cancer patients, parents of autistic children, and grown children of parents with Alzheimer's or Parkinson's disease.

''Our analysis should serve as a valuable resource for contemporary debate concerning whether the US marketplace for stem cell interventions is adequately monitored and regulated by the FDA, the Federal Trade Commission, state medical boards, and other agencies tasked with promoting patient safety and accurate advertising,'' the authors conclude.

Latest articles

Nissan recalls nearly 643,000 Rogue SUVs in U.S. over engine and throttle defects

Nissan recalls nearly 643,000 Rogue SUVs in U.S. over engine and throttle defects

SBU says Ukrainian drones hit oil depot in Russia’s Pskov region

SBU says Ukrainian drones hit oil depot in Russia’s Pskov region

$250 billion power play: key deals from the 2026 India AI Impact Summit

$250 billion power play: key deals from the 2026 India AI Impact Summit

Ambani’s $110 billion bet: Reliance and Jio to build India’s sovereign AI backbone

Ambani’s $110 billion bet: Reliance and Jio to build India’s sovereign AI backbone

The agentic pivot: Google and Sea partner to expand AI tools for e-commerce and gaming

The agentic pivot: Google and Sea partner to expand AI tools for e-commerce and gaming

Nigeria and South Africa drive global stablecoin demand surge, study finds

Nigeria and South Africa drive global stablecoin demand surge, study finds

Cisco and Qunnect test real-world quantum network over New York fiber cables

Cisco and Qunnect test real-world quantum network over New York fiber cables

Uber to invest $100 million+ in autonomous charging hubs to accelerate robotaxi rollout

Uber to invest $100 million+ in autonomous charging hubs to accelerate robotaxi rollout

The $250 billion pivot: how 2026 became the year AI paid the rent

The $250 billion pivot: how 2026 became the year AI paid the rent